Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma
Immuno-Oncology and Technology · 2024-12 · 24 · 100714
DOI: 10.1016/j.iotech.2024.100714 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immuno-Oncology and Technology, 2024-12. Verfasst von I A J van Duin und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Philips, Stichting Hanarth Fonds, ZonMw.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht.
- Image Sciences Institute, University Medical Center Utrecht, Utrecht University, Utrecht.
- Medical Image Analysis, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven.
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht.
- Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht.
- Department of Medical Oncology, Zuyderland Medical Centre, Sittard-Geleen.
Förderung
- Philips
- Stichting Hanarth Fonds
- ZonMw
Zitieren
APA
van Duin, I. A. J., Schuiveling, M., Ter Maat, L. S., Veta, M., van Eijs, M. J. M., Verheijden, R. J., van den Berkmortel, F. W. P. J., Boers-Sonderen, M. J., Hospers, G. A. P., Labots, M., de Groot, J. W. B., Kapiteijn, E., Piersma, D., Vreugdenhil, G., Westgeest, H., Schrader, A. M. R., van Diest, P. J., Blokx, W. A. M., & Suijkerbuijk, K. P. M. (2024). Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma. Immuno-Oncology and Technology, 24, 100714. https://doi.org/10.1016/j.iotech.2024.100714
Vancouver
van Duin IAJ, Schuiveling M, Ter Maat LS, Veta M, van Eijs MJM, Verheijden RJ, et al. Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma. Immuno-Oncology and Technology. 2024;24:100714. doi:10.1016/j.iotech.2024.100714
BibTeX
@article{vanDuin2024,
author = {van Duin, I A J and Schuiveling, M and Ter Maat, L S and Veta, M and van Eijs, M J M and Verheijden, R J and van den Berkmortel, F W P J and Boers-Sonderen, M J and Hospers, G A P and Labots, M and de Groot, J W B and Kapiteijn, E and Piersma, D and Vreugdenhil, G and Westgeest, H and Schrader, A M R and van Diest, P J and Blokx, W A M and Suijkerbuijk, K P M},
title = {Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma},
journal = {Immuno-Oncology and Technology},
year = {2024},
volume = {24},
pages = {100714},
doi = {10.1016/j.iotech.2024.100714}
}
EUVIMED